AKRO 44.03 ▼ -3.49% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akero Therapeutics Inc.

    NASDAQ: AKRO · Real-Time Price · USD
    44.03
    -1.59 (-3.49%)
    At close: Sep 04, 2025, 3:59 PM
    44.32
    0.66%
    Pre-market: Sep 05, 2025, 04:23 AM EDT
    -3.49%
    Bid 43.74
    Market Cap 3.52B
    Revenue (ttm) 4K
    Net Income (ttm) -283.96M
    EPS (ttm) -3.81
    PE Ratio (ttm) -11.56
    Forward PE -10.76
    Analyst Buy
    Ask 44.2
    Volume 1,333,327
    Avg. Volume (20D) 1,196,154
    Open 45.85
    Previous Close 45.62
    Day's Range 43.09 - 46.18
    52-Week Range 21.34 - 58.40
    Beta -0.24

    About AKRO

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol AKRO
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for AKRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts
    7 months ago
    +97.52%
    Akero Therapeutics shares are trading higher after... Unlock content with Pro Subscription
    news image

    1 week ago · zacks.com

    Has Akero Therapeutics (AKRO) Outpaced Other Medical Stocks This Year?

    Here is how Akero Therapeutics, Inc. (AKRO) and Stryker (SYK) have performed compared to their sector so far this year.

    news image

    1 week ago · zacks.com

    Does Akero Therapeutics (AKRO) Have the Potential to Rally 59.14% as Wall Street Analysts Expect?

    The average of price targets set by Wall Street analysts indicates a potential upside of 59.1% in Akero Therapeutics (AKRO). While the effectiveness of this highly sought-after metric is questionable,...

    news image

    3 weeks ago · zacks.com

    Are Medical Stocks Lagging Akero Therapeutics (AKRO) This Year?

    Here is how Akero Therapeutics, Inc. (AKRO) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

    news image

    4 weeks ago · fool.com

    Akero (AKRO) Q2 Loss Narrows 6%

    Akero (AKRO) Q2 Loss Narrows 6%

    news image

    2 months ago · accessnewswire.com

    Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Shareholders to Inquire about Securities Investigation

    NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero"or "the Company") ...

    news image

    3 months ago · accessnewswire.com

    Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Connect

    NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero"or "the Company") ...

    Add to Watchlist